Clinical Trials Directory

Trials / Completed

CompletedNCT04549103

Effect of Baduanjin on Functional Performance in Pre-Frail/Frail Older Adults

Effect of Community-based Baduanjin (八段锦) on Functional Performance in Pre-Frail/Frail Older Adults: A Randomised Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
58 (actual)
Sponsor
Geriatric Education and Research Institute · Other Government
Sex
All
Age
55 Years
Healthy volunteers
Not accepted

Summary

The aim for this study is to investigate the effectiveness of a 16-week realistic community-delivered Baduanjin training program compared to a waitlist control intervention, in improving functional outcomes among pre-frail and frail older adults in Singapore. It is hypothesized that participants that receive 16-week of BDJ training will have significant improvement in physical function (including balance, muscle strength, and endurance); alleviate exhaustion; reduce risk of falling and fear of falling; potentially reverse frailty; reduce depression; and improve quality of life, potentially with greater improvements in area(s) for individuals with lower baseline measures. Whereas, participants in the waitlist control group, will have insignificant changes to their baseline measures.

Conditions

Interventions

TypeNameDescription
OTHERBaduanjin exercise programBaduanjin (BDJ), also known as Eight-Section Brocades, is one of the forms of traditional Chinese Qigong exercises, characterized by symmetrical physical posture, movements, mindfulness, and breathing. Its primary focus is on the release of 'Qi' or internal body energy with the intent of improving health outcomes. BDJ encompasses eight simple movements involving combinations of postures, meditation, slow relaxing movements, and breathing exercises. It is a low intensity exercise, which have been found to improve range of motion, strength and general health. The simplicity and low intensity level is ideal for older adults to practice at home using instructional videos.

Timeline

Start date
2021-04-30
Primary completion
2023-11-14
Completion
2023-11-14
First posted
2020-09-16
Last updated
2024-02-02

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT04549103. Inclusion in this directory is not an endorsement.